Genomics of Drug Sensitivity in Cancer |
KIN001-266
|
Synonyms |
|
Targets |
MAP3K8
|
Target pathway |
Other, kinases
|
PubCHEM ID |
44143370
|
Jsmol |
|
Download molecule |
44143370
|
PUBCHEM IUPAC INCHI |
InChI=1S/C26H25Cl2FN8/c1-2-36-7-5-20(6-8-36)37-15-19(34-35-37)14-31-18-9-21-25(33-17-3-4-24(29)22(27)10-17)16(12-30)13-32-26(21)23(28)11-18/h3-4,9-11,13,15,20,31H,2,5-8,14H2,1H3,(H,32,33)
|
Smiles |
ClC=2(C1(=NC=C(C#N)C(=C1C=C(C=2)NCC=3(N=NN(C=3)C4(CCN(CC)CC4)))NC5(=CC(Cl)=C(F)C=C5)))
|
Cluster number |
35
|
calculated LogS |
-6,351
|
Molecular weight |
539,445
|
calculated LogP |
4,6769
|
H-Acceptors |
8
|
H-Donors |
2
|
Ro5 violations |
1
|
Druglikeness |
-2,3182
|
DrugScore |
0,107723699962004
|
Mutagenic |
high
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Fish Toxicity |
High FHMT
|
Fish Toxicity2 |
1,1987
|
Rat Acute Toxicity |
2,8004
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2-
|
Caco-2 Permeability2 |
0,5157
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Inhibitor
|
P-glycoprotein Inhibitor2 |
Inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Strong inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
0,7518
|
AMES Toxicity |
AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 3A4 Inhibitor |
Inhibitor
|
CYP450 2C19 Inhibitor |
Inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Non-carcinogens
|
Carcinogens |
Non-required
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
Low HBT
|
Renal Organic Cation Transporter |
Inhibitor
|
Subcellular localization |
Nucleus
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-3,5183
|